From: Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial
Variables | Main group, n = 208 | Control group, n = 64 | ||
Baseline | 24-week | Baseline | 24-week | |
Immunoassay insulin (nU/L) | 23.2 ± 1.0 | 6.5 ± 0.3* | 20.9 ± 1.2 | 15.0 ± 1.2* |
Immunoassay cortisol (nmol/L) | 751.2 ± 6.7 | 445.7 ± 5.3* | 747.2 ± 8.9 | 739.5 ± 9.1 |
HOMA-IR index | 8.9 ± 0.44 | 1.30 ± 0.29* | 7.97 ± 0.53 | 4.03 ± 0.55* |
Variable in men | ||||
Main group, n = 99 | Control group, n = 30 | |||
Blood testosterone (ng/dL) | 365.9 ± 13.8 | 885.2 ± 21.2* | 379.2 ± 19.6 | 395.2 ± 24.5 |